International Society for Pharmacoepidemiology (ISPE)

The International Society for Pharmacoepidemiology (ISPE) is an international organization dedicated to advancing the health of the public by providing a global forum for the open exchange of scientific information and for the development of policy, education, and advocacy for the field of pharmacoepidemiology, including such areas as pharmacovigilance, drug utilization research, comparative effectiveness review, and therapeutic risk management.

Pharmacoepidemiology is a scientific discipline that uses epidemiological methods to evaluate the use, benefits and risks of ‎medical products and interventions in human populations.

ISPE is committed to providing an unbiased scientific forum to the views of all parties with interests in drug development, drug delivery, drug use, drug costs, and drug effects.

ISPE members represent the various scientific disciplines involved in studying drugs. Members are employed by the pharmaceutical industry, academic institutions, government agencies, non-profit and for-profit private organizations. Members have degrees in a number of fields, including epidemiology, biostatistics, medicine, nursing, pharmacology, pharmacy, law, health economics, and journalism. With members in 53 countries and national chapters in Argentina, Belgium, Denmark, and the Netherlands, ISPE truly provides an international forum for sharing knowledge and scientific approaches to foster the science of pharmacoepidemiology.

Mission:
The International Society for Pharmacoepidemiology (ISPE) is an international organization dedicated to advancing the health of the public by providing a global forum for the open exchange of scientific information, collaboration, and the development of new epidemiologic research methods, policy, education, advocacy, and leadership for the field of pharmacoepidemiology.

Vision:
The objectives of the Society include:
1. Establishing scientific fora
2. Disseminating scholarly and practical pharmacoepidemiology information
3. Supporting and informing international policy regarding evaluation of benefits and harms of medical products and interventions in human populations
4. Facilitating professional communication
5. Building capacity for inclusive global collaboration in pharmacoepidemiology
6. Providing and facilitating education in pharmacoepidemiology
7. Facilitating collaboration within and across sectors within the Society, external organizations, and complementary disciplines.